Movie Industry

A Perfect Collaboration of Actors, Screenplay, and Direction… '100 Days of Lies' [Star Review]

Choi Hee-jae
2026-10-29 06:00:03
Reporters from E-Daily’s Culture Department introduce major movies, performances, and TV dramas to readers through candid reviews and star ratings. <Editor’s Note>

A scene from the drama “100 Days of Lies.” (Photo: tvN)

◇Drama “100 Days of Lies”
★★★★☆ I’m proud that international viewers are watching this drama. A superb combination of actors, script, and direction. (ReporterGim Ga Yeong )
★★★★☆ A story that hasn’t even spanned 100 years yet. Even though we already know how this drama ends. (ReporterChoi Hee-jae )
★★★★☆ A well-made period drama that makes you want to tune in live. (ReporterYUN GI BACK )

A scene from the film “Paradise Lost.” (Photo courtesy of CJ ENM)

◇The movie “Paradise Lost”
★★★☆ Yeon Sang-ho’s imagination, which portrays unconventional concepts and pushes boundaries. (ReporterChoi Hee-jae )
★★★ Typical Yeon Sang-ho. (ReporterYUN GI BACK )

A scene from the film “Still Radiant.” (Photo courtesy of Plus M Entertainment)

◇The movie “Still Radiant”
★★★★ A generous display of stellar performances. (ReporterYUN GI BACK )

A scene from the movie “Steel Ray.” (Photo courtesy of Raon Company Plus)

◇The movie “Steel Ray”
★★★★ An unexpected gem. With this level of quality, even AI-generated films are highly competitive. (ReporterYUN GI BACK )

※Rating=★★★★★ (out of 5, ☆ represents half a star; the more stars, the more recommended)

Economy

Corporation

IT·Science

Economy

"Semiconductor Revenue Alone Expected to Reach 110 Trillion Won" SamsungElectronics to Release Earnings Today… Will There Be a "Generous Bonus"?

SamsungElectronics will announce its final third-quarter earnings today (the 29th). With the semiconductor supercycle continuing amid expanded investment in artificial intelligence (AI), forecasts sug…
2026-10-29 04:50:03

Corporation

[Exclusive Interview] Biohaven: “BHV-1530 Expected to Be ‘First in Its Class,’ Surpasses Lilly’s Compound”

“The FGFR3-targeted antibody-drug conjugate (ADC) ‘BHV-1530 (AMB302)’ has demonstrated confirmed tumor responses in urothelial carcinoma and head and neck cancer. This can be considered a significant …
2026-10-29 07:37:02

IT·Science

Voronoi, Inc. Reduced Clinical Trial Participants by 35%, but... Why It Is Seeking Additional Funding

Attention is focusing on the reasons behind the sharp rise in clinical development costs at Voronoi, Inc.(310210), a developer of new lung cancer drugs, even though the company reduced its target pati…
2026-10-29 08:01:02